Prognostic Impact of Residual T and N Status After Neoadjuvant Therapy in Breast Cancer
Residual T and N positivity after NST represents a simple yet powerful prognostic indicator in breast cancer. This two-factor classification, easily derived from routine pathology, may serve as a practical reference for post-NST risk stratification and inform decisions regarding additional adjuvant treatment.
Authors
- Chika Watanabe (ORCID: https://orcid.org/0000-0003-4905-3798)
- Shinichiro Kashiwagi (ORCID: https://orcid.org/0000-0002-0460-9599)
- Masatsune SHIBUTANI
- Haruhito Kinoshita
- Keiko Yoshimura
- TAMAMI MORISAKI
- SAE FUJIOKA
- Koji Takada
- YUKIE TAUCHI
- KANA OGISAWA
- YUKO KIKUKAWA
Institutions
- Osaka City University (JP)
- Saiseikai Nakatsu Hospital (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2026-01-30
- DOI
- https://doi.org/10.21873/anticanres.18000
- Citations
- 1
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 24.82